Andrew Combs
Chief Chemistry Officer · 1 filing · Latest: Feb 4, 2026
Prelude Therapeutics Inc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
Chief Chemistry Officer · 1 filing · Latest: Feb 4, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|